BRIEF-Voyager Therapeutics says on track to report top-line human proof-of-concept data for VY-AADC01 in Q4 of 2016
April 29, 2016 at 12:11 PM EDT
* Voyager remains on track to report top-line human proof-of-concept data for VY-AADC01 in Q4 of 2016
